Preview

Problems of Endocrinology

Advanced search

Familial case of normosmic hypogonadotropic hypogonadism with polydactyly, associated with defect of FGFR1 gene

https://doi.org/10.14341/probl8706

Abstract

Congenital isolated hypogonadotropic hypogonadism refers to a group of predominantly monogenic diseases associated with impaired production, secretion, and/or action of the gonadotropin-releasing hormone (GnRH), which leads to a pronounced delay or absence of puberty. Clinical and genetic heterogeneity is typical of this group of diseases. To date, about 30 candidate genes associated with the development of various forms of secondary hypogonadism are known. Congenital hypogonadotropic hypogonadism can be verified only using molecular genetic diagnostics. The correct diagnosis is necessary for predicting the disease course and choosing the proper approach for managing the patient. We describe a familial case of normosmic hypogonadotropic hypogonadism and late puberty associated with a mutation in the FGFR1 gene. The case is interesting because of pronounced phenotypic manifestations and their high concentration in the proband’s family history. Also of interest is the phenotype untypical of mutations in this gene. The molecular genetic study was performed using new generation sequencing with the authors’ panel of primers and a PGM semiconductor sequencer (Ion Torrent). The Sanger method was used to confirm the identified mutation and examine the proband’s relative. In both patients, a heterozygous mutation in the FGFR1 gene, previously described in Kallmann syndrome, was detected.

About the Authors

Maria V. Gerasimova

Endocrinology Research Centre


Russian Federation

MD



Natalya U. Kalinchenko

Endocrinology Research Centre


Russian Federation

MD, PhD



Evgeniy V. Vasiliev

Endocrinology Research Centre


Russian Federation

PhD



Vasiliy M. Petrov

Endocrinology Research Centre


Russian Federation

PhD



Anatoly N. Tiulpakov

Endocrinology Research Centre


Russian Federation

MD, PhD



References

1. Ornitz DM, Itoh N. The Fibroblast Growth Factor signaling pathway. Wiley Interdiscip Rev Dev Biol. 2015;4(3):215-266. doi: 10.1002/wdev.176

2. Goetz R, Mohammadi M. Exploring mechanisms of FGF signalling through the lens of structural biology. Nat Rev Mol Cell Biol. 2013;14(3):166-180. doi: 10.1038/nrm3528

3. Goetz R, Dover K, Laezza F, et al. Crystal structure of a fibroblast growth factor homologous factor (FHF) defines a conserved surface on FHFs for binding and modulation of voltage-gated sodium channels. J Biol Chem. 2009;284(26):17883-17896. doi: 10.1074/jbc.M109.001842

4. Powers C. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer. 2000;7(3):165-197. doi: 10.1677/erc.0.0070165

5. Ornitz DM, Itoh N. Fibroblast growth factors. Genome Biol. 2001;2(3):REVIEWS3005. PMC138918

6. Eswarakumar VP, Lax I, Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005;16(2):139-149. doi: 10.1016/j.cytogfr.2005.01.001

7. Albuisson J, Pecheux C, Carel JC, et al. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat. 2005;25(1):98-99. doi: 10.1002/humu.9298

8. Dode C, Levilliers J, Dupont JM, et al. Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet. 2003;33(4):463-465. doi: 10.1038/ng1122

9. Pitteloud N, Acierno JS, Jr., Meysing A, et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA. 2006;103(16):6281-6286. doi: 10.1073/pnas.0600962103

10. Seminara SB, Beranova M, Oliveira LM, et al. Successful use of pulsatile gonadotropin-releasing hormone (GnRH) for ovulation induction and pregnancy in a patient with GnRH receptor mutations. J Clin Endocrinol Metab. 2000;85(2):556-562. doi: 10.1210/jcem.85.2.6357

11. Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117(2):457-463. doi: 10.1172/JCI29884

12. Raivio T, Sidis Y, Plummer L, et al. Impaired fibroblast growth factor receptor 1 signaling as a cause of normosmic idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2009;94(11):4380-4390. doi: 10.1210/jc.2009-0179

13. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. Fibroblast growth factor receptor 1 [Internet]. http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FGFR1

14. Online Mendelian Inheritance in Man. Fibroblast growth factor receptor 1; FGFR1 [Internet]. http://omim.org/entry/136350?search=FGFR1&highlight=fgfr1


Supplementary files

1. Рисунок 1. Родословная пациента.
Subject
Type Исследовательские инструменты
View (58KB)    
Indexing metadata ▾

Review

For citations:


Gerasimova M.V., Kalinchenko N.U., Vasiliev E.V., Petrov V.M., Tiulpakov A.N. Familial case of normosmic hypogonadotropic hypogonadism with polydactyly, associated with defect of FGFR1 gene. Problems of Endocrinology. 2018;64(1):38-41. https://doi.org/10.14341/probl8706

Views: 1111


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)